Literature DB >> 21852620

Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies.

Gregory W Albers1, Larry B Goldstein, David C Hess, Lawrence R Wechsler, Karen L Furie, Philip B Gorelick, Patty Hurn, David S Liebeskind, Raul G Nogueira, Jeffrey L Saver.   

Abstract

BACKGROUND AND
PURPOSE: The goal of the Stroke Treatment Academic Industry Roundtable (STAIR) meetings is to advance the development of acute and restorative stroke therapies. Summary of Review- At the STAIR VII recommendations for strategies to maximize the use of intravenous thrombolytics through targeting public education, and the refinement of current treatment exclusion criteria were proposed. Increased utilization of mechanical devices for intra-arterial recanalization can be achieved by obtaining more definitive evidence of efficacy in randomized clinical trials, identification of patient characteristics associated with treatment efficacy, optimization of technical approaches, clarification of effective time windows, and development of approaches to limit complications. Neuroprotective strategies remain viable; recommendations for further study of these agents include an emphasis on rapid administration, consideration of the systemic effects of ischemic stroke, prevention of complications associated with early reperfusion, a focus on agents with multiple mechanisms of action, and consideration of possible interactions between neuroprotective and thrombolytic therapies.
CONCLUSIONS: Extending intravenous thrombolysis to a broader patient population, clarifying the risk and benefits of intra-arterial reperfusion therapies, and further development of neuroprotective therapies were the key recommendations from STAIR VII.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852620     DOI: 10.1161/STROKEAHA.111.618850

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  97 in total

1.  Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

Authors:  Diana Amantea; Michelangelo Certo; Francesco Petrelli; Giacinto Bagetta
Journal:  Assay Drug Dev Technol       Date:  2016-07-08       Impact factor: 1.738

2.  Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

Authors:  Paul A Lapchak; Jacqueline M Lara; Paul D Boitano
Journal:  Transl Stroke Res       Date:  2017-04-12       Impact factor: 6.829

Review 3.  Brain imaging in acute ischemic stroke—MRI or CT?

Authors:  Heinrich J Audebert; Jochen B Fiebach
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

4.  The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein.

Authors:  TaeHee Kim; Suresh L Mehta; Kahlilia C Morris-Blanco; Anil K Chokkalla; Bharath Chelluboina; Mary Lopez; Ruth Sullivan; Hung Tae Kim; Thomas D Cook; Joo Yong Kim; HwuiWon Kim; Chanul Kim; Raghu Vemuganti
Journal:  Sci Signal       Date:  2018-12-11       Impact factor: 8.192

5.  A peptide mimetic of tyrosine phosphatase STEP as a potential therapeutic agent for treatment of cerebral ischemic stroke.

Authors:  Ranjana Poddar; Sathyanarayanan Rajagopal; Lucas Winter; Andrea M Allan; Surojit Paul
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-07       Impact factor: 6.200

6.  Clinical trials for neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside.

Authors:  Amit Ayer; Brian Y Hwang; Geoffrey Appelboom; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-08-14       Impact factor: 6.829

Review 7.  Improving the translation of animal ischemic stroke studies to humans.

Authors:  Glen C Jickling; Frank R Sharp
Journal:  Metab Brain Dis       Date:  2014-02-15       Impact factor: 3.584

8.  Middle Cerebral Artery Occlusion Model of Stroke in Rodents: A Step-by-Step Approach.

Authors:  Shima Shahjouei; Peter Y Cai; Saeed Ansari; Sharareh Sharififar; Hassan Azari; Sarah Ganji; Ramin Zand
Journal:  J Vasc Interv Neurol       Date:  2016-01

9.  BDNF mediates neuroprotection against oxygen-glucose deprivation by the cardiac glycoside oleandrin.

Authors:  Michael J Van Kanegan; Dong Ning He; Denise E Dunn; Peiying Yang; Robert A Newman; Anne E West; Donald C Lo
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

Review 10.  Mitochondrial mechanisms of neuronal rescue by F-68, a hydrophilic Pluronic block co-polymer, following acute substrate deprivation.

Authors:  Janice C Wang; Vytautas P Bindokas; Matthew Skinner; Todd Emrick; Jeremy D Marks
Journal:  Neurochem Int       Date:  2017-04-19       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.